[Federal Register Volume 65, Number 163 (Tuesday, August 22, 2000)]
[Notices]
[Pages 51002-51003]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-21350]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the meeting of 
the National Cancer Advisory Board.
    The meeting will be open to the public as indicated below, with 
attendance limited to space available. Individuals who plan to attend 
and need special assistance, such as sign language interpretation or 
other reasonable accommodations, should notify the Contact Person 
listed below in advance of the meeting.
    A portion of the meeting will be closed to the public in accordance 
with the provisions set forth in sections 552b(c)(6) and 552b(c)(9), 
title 5 U.S.C., as amended. The discussions could disclose confidential 
trade secrets or commercial property such as patentable material, and 
personal information concerning individuals associated with the review 
of applications, and information concerning NCI and/or its contractors, 
the disclosure of which would constitute a clearly unwarranted invasion 
of personal privacy, and the premature disclosure of discussions 
related to personnel and programmatic issues would be likely to 
significantly frustrate the subsequent implementation of 
recommendations.

    Name of Committee: National Cancer Advisory Board.
    Dates: September 11-13, 2000.

    Name of Committee: National Cancer Advisory Board, Subcommittee 
on Communications, Subcommittee on Clinical Investigations and 
Subcommittee on Confidentiality.
    Open: September 11, 7 pm to 9 pm.
    Agenda: To discuss activities related to the implementation of 
policies relevant to the functional responsibilities of each 
specific subcommittee.
    Place: Bethesda Hyatt Regency, One Bethesda Metro Center, 
Bethesda, MD 20814, (301) 657-1234.

    Name of Committee: National Cancer Advisory Board.
    Dates: September 11-13, 2000.
    Open: September 12, 9 am to 12 pm.
    Agenda: Program reports and presentations; Business of the 
Board. For detailed agenda: See NCI Homepage/Advisory Board and 
Groups http://deainfo.nci.nih.gov/ADVISORY/boards.htm Tentative 
agenda available 10 working days prior to meetings; Final agenda 
available 5 working days prior to meetings.

    Name of Committee: National Cancer Advisory Board, Subcommittee 
on Planning and Budget.

[[Page 51003]]

    Open: September 12, 12:10 pm to 1:10 pm.
    Agenda: To discuss activities related to the Subcommittee on 
Planning and Budget.
    Open: September 12, 1:15 pm to 3:45 pm.
    Agenda: Program reports and presentations; Business of the 
Board. For detailed agenda: See NCI Homepage/Advisory Board and 
Groups http://deainfo.nci.nih.gov/ADVISORY/boards.htm Tentative 
agenda available 10 working days prior to meetings; Final agenda 
available 5 working days prior to meetings.
    Closed: September 12, 4 pm to Recess.
    Agenda: To review and evaluate grant applications and discuss 
information of a confidential nature.
    Place: Building 31, C Wing, 6 Floor, Conference Room 10, 
National Institutes of Health, 9000 Rockville Pike, Bethesda, MD 
20892.
    Open: September 13, 9 am to 12:35 pm.
    Agenda: Program reports and presentations; Business of the 
Board. For detailed agenda: See NCI Homepage/Advisory Board and 
Groups http://deainfo.nci.nih.gov/ADVISORY/boards.htm Tentative 
agenda available 10 working days prior to meetings; Final agenda 
available 5 working days prior to meetings.
    Place: Building 31, C Wing, 6 Floor, Conference Room 10, 
National Institutes of Health, 9000 Rockville Pike, Bethesda, MD 
20892.
    Contact Person: Marvin R. Kalt, Executive Secretary, National 
Cancer Institute, National Institutes of Health, 6116 Executive 
Boulevard, 8th Floor, Room 8022, Bethesda, MD 20892-8327, (301) 496-
5147.
    This meeting is being published less than 15 days prior to the 
meeting due to scheduling conflicts.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: August 16, 2000.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 00-21350 Filed 8-21-00; 8:45 am]
BILLING CODE 4140-01-M